TrialEuropean journal of clinical pharmacology2012

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects.

Teddy Kosoglou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.